Grifols announces next-gen automated system for transfusion labs
Evanzys IH is modular and track-enabled, reducing manual intervention. It expands Grifols' portfolio of blood typing solutions.
See the latest news and media coverage for Grifols. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global healthcare company focused on plasma-derived medicines and diagnostics
grifols.comLast updated
In short: Grifols reported strong 2026 Q1 financial growth, advanced major debt refinancing, and faced Canadian regulatory scrutiny following donor deaths.
Evanzys IH is modular and track-enabled, reducing manual intervention. It expands Grifols' portfolio of blood typing solutions.
The plan is built around six key pillars for responsible practices across the business.
The EUR 160 million plant will boost plasma fractionation capacity by three million liters annually.
Results show solid start driven by Biopharma strength, immunoglobulin portfolio, efficiency, refinancing, and strategic projects in Egypt and Canada.
Grifols approved at its June 18 meeting to reduce up to 10% of its capital through the amortization of its own class A shares and...
Grifols approves buybacks, studies Nasdaq and advances with Biopharma to reduce debt and improve its stock market valuation.
Grifols confirms at its meeting that it is progressing on its 2025 plan, beats record revenue and profit, and maintains debt reduction as a priority.
Shareholders give green light for the board to request that class A shares be listed on the US Nasdaq...
Track Grifols and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.